Based on the data retrieved from the TogoVar API, there is no direct mention of rs121913279 being included in pharmacogenomics guidelines such as PharmGKB. However, the variant is associated with the PIK3CA gene, which is known to play a role in cancer pathways and targeted therapies. For example, PIK3CA mutations are relevant in the context of PI3K inhibitors used in cancer treatment. To confirm its inclusion in specific pharmacogenomics guidelines, further investigation in databases like PharmGKB or other pharmacogenomics resources would be necessary.

### English Summary:
1. **Variant Identification**:  
   - **rs number**: rs121913279  
   - **Gene**: PIK3CA  
   - **Transcript**: NM_006218.4:c.3140A>G (p.His1047Arg) and NM_006218.4:c.3140A>T (p.His1047Leu)  
   - [dbSNP link](https://identifiers.org/dbsnp/rs121913279)  

2. **Disease Associations**:  
   - Associated with various cancers (e.g., breast cancer, colorectal cancer, ovarian cancer) and syndromes like CLOVES syndrome.  

3. **Literature Evidence**:  
   - No specific pharmacogenomics-related publications were retrieved from TogoVar.  

4. **Allele Frequency Comparison**:  
   - The allele frequency for the A>G variant in the Japanese population is 6.579e-05 (source: gem_j_wga). No frequency data for A>T was provided.  

5. **GWAS Findings**:  
   - No GWAS findings were retrieved from TogoVar.  

6. **TogoVar Link**:  
   - [TogoVar page for rs121913279](https://togovar.org/variant/tgv15260121)  

### Japanese Summary:
1. **バリアント識別**:  
   - **rs番号**: rs121913279  
   - **遺伝子**: PIK3CA  
   - **トランスクリプト**: NM_006218.4:c.3140A>G (p.His1047Arg) および NM_006218.4:c.3140A>T (p.His1047Leu)  
   - [dbSNPリンク](https://identifiers.org/dbsnp/rs121913279)  

2. **疾患関連**:  
   - 乳癌、大腸癌、卵巣癌などの様々な癌やCLOVES症候群などに関連。  

3. **文献証拠**:  
   - TogoVarから薬理ゲノミクス関連の特定の文献は取得されていません。  

4. **アレル頻度比較**:  
   - 日本人集団におけるA>Gバリアントのアレル頻度は6.579e-05（gem_j_wgaより）。A>Tの頻度データは提供されていません。  

5. **GWASの発見**:  
   - TogoVarからGWAS関連の情報は取得されていません。  

6. **TogoVarリンク**:  
   - [TogoVarページ rs121913279](https://togovar.org/variant/tgv15260121)  

For further confirmation, consult PharmGKB or similar pharmacogenomics databases.  
PharmGKBの確認が必要です。